DE3785740D1 - Verwendung von carboxamid-verbindungen zur herstellung eines arzneimittels zur behandlung der hyperlipaemie. - Google Patents

Verwendung von carboxamid-verbindungen zur herstellung eines arzneimittels zur behandlung der hyperlipaemie.

Info

Publication number
DE3785740D1
DE3785740D1 DE8787119319T DE3785740T DE3785740D1 DE 3785740 D1 DE3785740 D1 DE 3785740D1 DE 8787119319 T DE8787119319 T DE 8787119319T DE 3785740 T DE3785740 T DE 3785740T DE 3785740 D1 DE3785740 D1 DE 3785740D1
Authority
DE
Germany
Prior art keywords
hyperlipaemia
treatment
production
medicinal product
carboxamide compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787119319T
Other languages
English (en)
Other versions
DE3785740T2 (de
Inventor
Kazuhiko Tsutsumi
Tagui Sugimoto
Yoshihiko Tuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Original Assignee
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd, Otsuka Pharmaceutical Factory Inc filed Critical Otsuka Pharmaceutical Co Ltd
Publication of DE3785740D1 publication Critical patent/DE3785740D1/de
Application granted granted Critical
Publication of DE3785740T2 publication Critical patent/DE3785740T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE87119319T 1986-12-29 1987-12-29 Verwendung von Carboxamid-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung der Hyperlipämie. Expired - Lifetime DE3785740T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31326786 1986-12-29
JP62317246A JPH0651625B2 (ja) 1986-12-29 1987-12-14 高脂質血症治療剤

Publications (2)

Publication Number Publication Date
DE3785740D1 true DE3785740D1 (de) 1993-06-09
DE3785740T2 DE3785740T2 (de) 1993-10-21

Family

ID=26567502

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87119319T Expired - Lifetime DE3785740T2 (de) 1986-12-29 1987-12-29 Verwendung von Carboxamid-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung der Hyperlipämie.

Country Status (5)

Country Link
US (1) US5081112A (de)
EP (1) EP0273444B1 (de)
JP (1) JPH0651625B2 (de)
KR (1) KR940000008B1 (de)
DE (1) DE3785740T2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0651625B2 (ja) * 1986-12-29 1994-07-06 株式会社大塚製薬工場 高脂質血症治療剤
AU606808B2 (en) * 1988-06-29 1991-02-14 Otsuka Pharmaceutical Factory, Inc. Arylcarboxamide substituted by alkylphosphonates, process for preparing the same and a pharmaceutical composition containing the same
JP2584336B2 (ja) * 1989-05-30 1997-02-26 株式会社大塚製薬工場 カルボン酸アミド誘導体
JP2835545B2 (ja) * 1990-11-27 1998-12-14 株式会社大塚製薬工場 白内障予防及び治療剤
JP2835547B2 (ja) * 1991-12-25 1998-12-14 株式会社大塚製薬工場 糖尿病治療剤
TW260664B (de) * 1993-02-15 1995-10-21 Otsuka Pharma Factory Inc
US5624918A (en) * 1993-06-17 1997-04-29 Otsuka Pharmaceutical Factory, Inc. Phosphonic diester derivatives
ES2141830T3 (es) * 1993-08-20 2000-04-01 Otsuka Pharma Co Ltd Derivado de diester fosfonico.
CA2241679C (en) * 1995-12-27 2002-02-12 Otsuka Pharmaceutical Factory, Inc. Phosphonic acid diester derivatives
TW570799B (en) * 1998-02-17 2004-01-11 Otsuka Pharma Co Ltd The agent for preventing and curing fatty liver
ME00116B (me) * 2003-08-11 2010-10-10 Hoffmann La Roche Piperazin sa ili supstituisanom fenil grupom i njihova upotreba kao inhibitora glyt1
US9409856B2 (en) 2005-11-28 2016-08-09 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US8637706B2 (en) * 2005-11-28 2014-01-28 Gtx, Inc. Nuclear receptor binding agents
US8546451B2 (en) 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
MX2010001784A (es) 2007-08-13 2010-03-15 Metabasis Therapeutics Inc Activadores novedosos de la glucocinasa.
US9624161B2 (en) 2009-02-23 2017-04-18 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US9427418B2 (en) 2009-02-23 2016-08-30 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
WO2013078413A1 (en) * 2011-11-22 2013-05-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modulators of lipid storage
KR101432012B1 (ko) * 2013-02-19 2014-08-21 한국식품연구원 항비만용 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3073740A (en) * 1958-10-06 1963-01-15 Smith Kline French Lab Method of reducing cholesterol levels with tri- (dialkylaminoalkyl) phosphates
AU523040B2 (en) * 1978-05-15 1982-07-08 Kanebo Limited Calcium -antagonistic composition
GB2043072B (en) * 1979-02-13 1983-11-23 Symphar Sa Diphosphonate compounds
GB2043073B (en) * 1979-02-13 1983-05-11 Symphar Sa Mono-and diphosphonate compounds
US4416877A (en) * 1979-02-13 1983-11-22 Symphar S.A. Anti-atherosclerotic pharmaceutical compositions containing diphosphonate compounds
EP0185132B1 (de) * 1984-12-12 1988-08-10 Kanebo, Ltd. Ethyl-Benzylphosphinat-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Calcium-Antagonisten
JPS61151199A (ja) * 1984-12-26 1986-07-09 Otsuka Pharmaceut Factory Inc カルボン酸アミド誘導体
US4704382A (en) * 1985-07-29 1987-11-03 G. D. Searle & Co. Phenylpiperazine phosphonates
JPH0651625B2 (ja) * 1986-12-29 1994-07-06 株式会社大塚製薬工場 高脂質血症治療剤
US4822780A (en) * 1987-07-08 1989-04-18 Otsuka Pharmaceutical Factory, Inc. Carboxamide compounds

Also Published As

Publication number Publication date
EP0273444A3 (en) 1990-07-11
EP0273444A2 (de) 1988-07-06
EP0273444B1 (de) 1993-05-05
JPS63264421A (ja) 1988-11-01
US5081112A (en) 1992-01-14
KR940000008B1 (ko) 1994-01-05
KR880007085A (ko) 1988-08-26
DE3785740T2 (de) 1993-10-21
JPH0651625B2 (ja) 1994-07-06

Similar Documents

Publication Publication Date Title
DE3785740D1 (de) Verwendung von carboxamid-verbindungen zur herstellung eines arzneimittels zur behandlung der hyperlipaemie.
DE3585607D1 (de) Verwendung von paroxetine zur herstellung eines arzneimittel zur behandlung von obesitaet.
DE3769812D1 (de) Verwendung von phosphordiesteraseinhibitoren und cyclischen nukleotidanalogen zur herstellung eines arzneimittels zur stimulierung der traenensekretion.
DE3484055D1 (de) Verwendung von ubidecarenon zur herstellung eines medikaments zur behandlung von durch radiotherapie hervorgerufenen geschwueren.
DE58908534D1 (de) Verfahren zur Herstellung von doppelt-haploiden Gurken.
ATE66678T1 (de) Verfahren zur herstellung von makrolidderivaten.
DE3788057D1 (de) Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen.
DE68924714D1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
DE58908451D1 (de) Verfahren zur Herstellung von Organochlorsilanen.
DE3782028D1 (de) Verwendung von ketonderivaten zur behandlung von bewusstseinsstoerungen.
DE68913030D1 (de) Verfahren zur Herstellung von Propylen.
DE58906613D1 (de) Verfahren zur Herstellung von orthodontischen Teilen.
DE3768150D1 (de) Verwendung eines 1,3-oxazolidin-2-on-derivates zur herstellung eines arzneimittels zur behandlung von ischaemie.
DE3481057D1 (de) 2-sulfamoylbenzo(b)thiophen-derivate, ihre herstellung und pharmazeutische zubereitung zur behandlung von erhoehtem augeninnendruck.
DE69009682D1 (de) Verfahren zur Herstellung von Cyclohexanolderivaten.
DE3675115D1 (de) Verwendung von verbindungen zur herstellung eines medikaments fuer die behandlung von grauem star.
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE68916760D1 (de) Verfahren zur Herstellung von Gamma-Lactonen.
DE3873210D1 (de) Verwendung von benzylpyridin-derivaten zur herstellung eines arzneimittels zur behandlung der demenz.
ATE86619T1 (de) Verfahren zur herstellung von nitroethenderivaten.
DE3686097D1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
DE68920087D1 (de) Verfahren zur Herstellung von Neuraminidase.
PT87301A (pt) Process for the preparation of 1,3-dioxanes by products and of pharmaceutical compounds containing them
PT70560A (de) 1,3,4-thiadiazol-2-carbonsaure-derivate verfahren zur herstellung dieser verbindungen sowie diese enthaltende fungizide und nematizide mittel
DE3483944D1 (de) Verwendung von selektiv peripheren dopamin-antagonisten zur herstellung eines arzneimittels zur topischen behandlung von okularer hypertension.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition